Uncategorized
NovaBay Pharmaceuticals Reports 2016 First Quarter Financial Results
EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay® Pharmaceuticals, Inc. (NYSE MKT: NBY), a biopharmaceutical company focusing on commercializing its prescription Avenova lid and lash hygiene product for the domestic eye care market, reports financial results for the three months ended March 31, 2016, and provides a business update. “Total sales for the quarter reached $1.7 million, up 5% sequentially; however, under our new pharmacy channel strategy, sales for the quarter on a non-GAAP basis would
